Literature DB >> 11342147

Selective protein interactions with phosphatidylserine containing liposomes alter the steric stabilization properties of poly(ethylene glycol).

G N Chiu1, M B Bally, L D Mayer.   

Abstract

Incorporation of 5 mol% poly(ethylene glycol)-conjugated lipids (PEG-lipids) has been shown to extend the circulation longevity of neutral liposomes due to steric repulsion of PEG at the membrane surface. The effects of PEG-lipids on protein interactions with biologically reactive membranes were examined using phosphatidylserine (PS) containing liposomes as the model. Incorporating 15 mol% 1,2-distearoyl-sn-glycero-3-phosphoethanolamine (DSPE)-PEG 2000 into PS liposomes resulted in circulation lifetimes comparable to that obtained with neutral liposomes containing 5 mol% DSPE-PEG 2000. These results suggested that 15 mol% DSPE-PEG 2000 may be effective in protecting PS liposomes from the high affinity, PS-mediated binding of plasma proteins. This was determined by monitoring the effects of PEG-lipids on calcium-mediated blood coagulation protein interactions with PS liposomes. Prothrombin binding and procoagulant activity of PS liposomes could be inhibited >80% when 15 mol% DSPE-PEG 2000 was used. These results are consistent with PS on membrane surfaces forming transient nucleation sites for protein binding that may result in lateral exclusion of PEG-lipids incorporated at <10 mol%. These nucleation sites may be inaccessible when PEG-lipids are present at elevated levels where they adopt a highly compressed brush conformation. This suggests that liposomes with reactive groups and PEG-lipids may be appropriately designed to impart selectivity to protein interactions with membrane surfaces.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11342147     DOI: 10.1016/s0005-2736(00)00335-7

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  8 in total

Review 1.  Drug delivery trends in clinical trials and translational medicine: challenges and opportunities in the delivery of nucleic acid-based therapeutics.

Authors:  Long Xu; Thomas Anchordoquy
Journal:  J Pharm Sci       Date:  2011-01       Impact factor: 3.534

2.  The effect of liposome encapsulation on the pharmacokinetics of recombinant secretory leukocyte protease inhibitor (rSLPI) therapy after local delivery to a guinea pig asthma model.

Authors:  Aileen Gibbons; Danielle Padilla-Carlin; Ciara Kelly; Anthony J Hickey; Clifford Taggart; Noel G McElvaney; Sally-Ann Cryan
Journal:  Pharm Res       Date:  2011-06-07       Impact factor: 4.200

3.  Passive transfer of polyethylene glycol to liposomal-recombinant human FVIII enhances its efficacy in a murine model for hemophilia A.

Authors:  Karthik Ramani; Vivek Purohit; Razvan Miclea; Puneet Gaitonde; Robert M Straubinger; Sathy V Balu-Iyer
Journal:  J Pharm Sci       Date:  2008-09       Impact factor: 3.534

4.  Noninvasive detection of macrophages in atheroma using a radiocontrast-loaded phosphatidylserine-containing liposomal contrast agent for computed tomography.

Authors:  Patrick Kee; Vaishali Bagalkot; Evan Johnson; Delia Danila
Journal:  Mol Imaging Biol       Date:  2015-06       Impact factor: 3.488

5.  Effect of pegylated phosphatidylserine-containing liposomes in experimental chronic arthritis.

Authors:  Paulo Cm Urbano; Vanete T Soccol; Vivian N Teixeira; Patrícia G Oliveira; Lidiane I Filippin; Wagner H Bonat; Carolina de Oliveira; Gustavo R Rossi; Ricardo M Xavier; Valderilio F Azevedo
Journal:  BMC Pharmacol Toxicol       Date:  2015-09-22       Impact factor: 2.483

6.  Spectroscopic and calorimetric studies on the interaction of human serum albumin with DPPC/PEG:2000-DPPE membranes.

Authors:  Manuela Pantusa; Luigi Sportelli; Rosa Bartucci
Journal:  Eur Biophys J       Date:  2008-04-04       Impact factor: 2.095

7.  Internalization of paramagnetic phosphatidylserine-containing liposomes by macrophages.

Authors:  Tessa Geelen; Sin Yuin Yeo; Leonie E M Paulis; Lucas W E Starmans; Klaas Nicolay; Gustav J Strijkers
Journal:  J Nanobiotechnology       Date:  2012-08-28       Impact factor: 10.435

Review 8.  Molecular Simulations of PEGylated Biomolecules, Liposomes, and Nanoparticles for Drug Delivery Applications.

Authors:  Hwankyu Lee
Journal:  Pharmaceutics       Date:  2020-06-10       Impact factor: 6.321

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.